Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biden Launches Effort To Strengthen US Pharmaceutical Supply Chain

Executive Order Kicks Off 100-Day Review Of US API Framework

Executive Summary

A fresh executive order from US president Joe Biden calls for short-term and long-term study, broad consultation, and co-ordination with allies on the domestic supply chain.

You may also be interested in...



AAM Welcomes Biden Moves To Strengthen Supply Chain

US president Joe Biden’s latest executive order directing a review of the API supply chain has been welcomed by the country’s off-patent industry.

AAM Lauds Biden’s Domestic Manufacturing Project

Executive orders signed by Joe Biden in the first days of his presidency to support the US pandemic response – including calling for a plan to bolster domestic manufacturing capabilities – have received a warm welcome from the AAM.

Initial List Of US Essential Medicines Focuses On Acute Care

US FDA excludes chronic care products from list of medicines bolstered by domestic production investment and federal procurement requirements.

Related Content

Topics

UsernamePublicRestriction

Register

GB150701

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel